BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10208484)

  • 1. P1A1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia.
    Cenarro A; Casao E; Civeira F; Jensen HK; Faergeman O; Pocoví M
    Atherosclerosis; 1999 Mar; 143(1):99-104. PubMed ID: 10208484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
    Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation.
    Ferrières J; Lambert J; Lussier-Cacan S; Davignon J
    Circulation; 1995 Aug; 92(3):290-5. PubMed ID: 7634440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
    Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
    Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype.
    Sun XM; Patel DD; Webb JC; Knight BL; Fan LM; Cai HJ; Soutar AK
    Arterioscler Thromb; 1994 Jan; 14(1):85-94. PubMed ID: 7903864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
    Gaudet D; Vohl MC; Julien P; Tremblay G; Perron P; Gagné C; Bergeron J; Moorjani S; Després JP
    Am J Cardiol; 1998 Aug; 82(3):299-305. PubMed ID: 9708657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
    Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
    Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the low-density lipoprotein receptor gene in Brazilian individuals with heterozygous familial hypercholesterolemia.
    Salazar LA; Cavalli SA; Hirata MH; Diament J; Forti N; Giannini SD; Nakandakare ER; Bertolami MC; Hirata RD
    Braz J Med Biol Res; 2000 Nov; 33(11):1301-4. PubMed ID: 11050659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach.
    Versmissen J; Oosterveer DM; Yazdanpanah M; Dehghan A; Hólm H; Erdman J; Aulchenko YS; Thorleifsson G; Schunkert H; Huijgen R; Vongpromek R; Uitterlinden AG; Defesche JC; van Duijn CM; Mulder M; Dadd T; Karlsson HD; Ordovas J; Kindt I; Jarman A; Hofman A; van Vark-van der Zee L; Blommesteijn-Touw AC; Kwekkeboom J; Liem AH; van der Ouderaa FJ; Calandra S; Bertolini S; Averna M; Langslet G; Ose L; Ros E; Almagro F; de Leeuw PW; Civeira F; Masana L; Pintó X; Simoons ML; Schinkel AF; Green MR; Zwinderman AH; Johnson KJ; Schaefer A; Neil A; Witteman JC; Humphries SE; Kastelein JJ; Sijbrands EJ
    Eur J Hum Genet; 2015 Mar; 23(3):381-7. PubMed ID: 24916650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature coronary heart disease and autosomal dominant hypercholesterolemia: Increased risk in women with LDLR mutations.
    Ahmad Z; Li X; Wosik J; Mani P; Petr J; McLeod G; Murad S; Song L; Adams-Huet B; Garg A
    J Clin Lipidol; 2016; 10(1):101-8.e1-3. PubMed ID: 26892126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.
    Cenarro A; Artieda M; Castillo S; Mozas P; Reyes G; Tejedor D; Alonso R; Mata P; Pocoví M; Civeira F;
    J Med Genet; 2003 Mar; 40(3):163-8. PubMed ID: 12624133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.
    Anderson JL; King GJ; Bair TL; Elmer SP; Muhlestein JB; Habashi J; Carlquist JF
    J Am Coll Cardiol; 1999 Mar; 33(3):727-33. PubMed ID: 10080474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
    Junyent M; Gilabert R; Jarauta E; Núñez I; Cofán M; Civeira F; Pocoví M; Mallén M; Zambón D; Almagro F; Vega J; Tejedor D; Ros E
    Atherosclerosis; 2010 Feb; 208(2):437-41. PubMed ID: 19717150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population.
    Yu W; Nohara A; Higashikata T; Lu H; Inazu A; Mabuchi H
    Atherosclerosis; 2002 Dec; 165(2):335-42. PubMed ID: 12417285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.
    Ridker PM; Hennekens CH; Schmitz C; Stampfer MJ; Lindpaintner K
    Lancet; 1997 Feb; 349(9049):385-8. PubMed ID: 9033464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia.
    Jensen HK; Jensen LG; Meinertz H; Hansen PS; Gregersen N; Faergeman O
    Atherosclerosis; 1999 Oct; 146(2):337-44. PubMed ID: 10532689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.